Efficacy and Safety of Exenatide Once Weekly Versus Metformin, Pioglitazone, and Sitagliptin Used as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4) A 26-week double-blind study
Pharmacology, Toxicology and Pharmaceutical Science
16
6%
Biochemistry, Genetics and Molecular Biology
11
4%
Agricultural and Biological Sciences
10
4%
Other
31
13%
Unknown
75
30%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 February 2026.
All research outputs
#2,234,653
of 34,492,055 outputs
Outputs from Diabetes Care
#3,231
of 13,300 outputs
Outputs of similar age
#13,846
of 304,087 outputs
Outputs of similar age from Diabetes Care
#21
of 118 outputs
Altmetric has tracked 34,492,055 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,300 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.1. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 304,087 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 118 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.
